Literature DB >> 12902479

Either of the CD45RB and CD45RO isoforms are effective in restoring T cell, but not B cell, development and function in CD45-null mice.

Sarah Ogilvy1, Christine Louis-Dit-Sully, Joanne Cooper, Robin L Cassady, Denis R Alexander, Nick Holmes.   

Abstract

The protein tyrosine phosphatase CD45 is expressed as a series of isoforms whose tissue and differentiation stage specificity is broadly conserved in evolution. CD45 has been shown to be an important regulator of a variety of functions in many different hemopoietic lineages. We have chosen an in vivo genetic complementation strategy to investigate the differential functions between isoforms. In this study, we report the characterization of transgenic mice which express the isoforms CD45RO or CD45RB as their only CD45 molecules, at a variety of expression levels and in the majority of hemopoietic lineages. Both CD45RO and CD45RB isoforms reconstitute thymocyte development in a CD45-null mouse background when expressed above a threshold level. The resulting mature T cells populate the peripheral lymphoid organs where they are found at normal frequency. Both CD45RO and CD45RB isoforms also permit T cell function in the periphery, although the threshold for normal function here appears to be set higher than in the thymus. In contrast, neither isoform is capable of fully restoring peripheral B cell maturation, even at levels approaching those in heterozygous CD45(+/-) mice in which maturation is normal. In vitro activation of B cells by Ag-receptor stimulation is only minimally complemented by these CD45RO and CD45RB transgenes. Our results suggest that CD45 isoforms play unique roles which differ between the T and B lineages.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12902479     DOI: 10.4049/jimmunol.171.4.1792

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Overexpression of CD45RA isoforms in carriers of the C77G mutation leads to hyporeactivity of CD4+CD25highFoxp3+ regulatory T cells.

Authors:  C Pokoyski; T Lienen; S Rother; E Schock; A Plege-Fleck; R Geffers; R Schwinzer
Journal:  Genes Immun       Date:  2015-09-10       Impact factor: 2.676

Review 2.  CD45: all is not yet crystal clear.

Authors:  Nick Holmes
Journal:  Immunology       Date:  2006-02       Impact factor: 7.397

3.  CD45RB Status of CD8+ T Cell Memory Defines T Cell Receptor Affinity and Persistence.

Authors:  Scott M Krummey; Anna B Morris; Jesica R Jacobs; Donald J McGuire; Satomi Ando; Katherine P Tong; Weiwen Zhang; Jennifer Robertson; Sara A Guasch; Koichi Araki; Christian P Larsen; Brian D Evavold; Haydn T Kissick; Mandy L Ford
Journal:  Cell Rep       Date:  2020-02-04       Impact factor: 9.423

4.  Quantitative differences in CD45 expression unmask functions for CD45 in B-cell development, tolerance, and survival.

Authors:  Julie Zikherman; Kristin Doan; Ramya Parameswaran; William Raschke; Arthur Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-30       Impact factor: 11.205

5.  CD45-Csk phosphatase-kinase titration uncouples basal and inducible T cell receptor signaling during thymic development.

Authors:  Julie Zikherman; Craig Jenne; Susan Watson; Kristin Doan; William Raschke; Christopher C Goodnow; Arthur Weiss
Journal:  Immunity       Date:  2010-03-26       Impact factor: 31.745

Review 6.  The impact of alternative splicing in vivo: mouse models show the way.

Authors:  Tarik Möröy; Florian Heyd
Journal:  RNA       Date:  2007-06-11       Impact factor: 4.942

7.  Novel tools to dissect the dynamic regulation of TCR signaling by the kinase Csk and the phosphatase CD45.

Authors:  Ying Xim Tan; Julie Zikherman; Arthur Weiss
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2013-10-07

8.  Combinations of CD45 isoforms are crucial for immune function and disease.

Authors:  Ritu Dawes; Svetla Petrova; Zhe Liu; David Wraith; Peter C L Beverley; Elma Z Tchilian
Journal:  J Immunol       Date:  2006-03-15       Impact factor: 5.422

Review 9.  Regulation of TCR signalling by tyrosine phosphatases: from immune homeostasis to autoimmunity.

Authors:  Stephanie M Stanford; Novella Rapini; Nunzio Bottini
Journal:  Immunology       Date:  2012-09       Impact factor: 7.397

10.  CD45RO enriches for activated, highly mutated human germinal center B cells.

Authors:  Stephen M Jackson; Natessa Harp; Darshna Patel; Jeffrey Zhang; Savannah Willson; Yoon J Kim; Christian Clanton; J Donald Capra
Journal:  Blood       Date:  2007-07-20       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.